From the inception, Biopharma has been trying to transform its local endeavor to international arena with a view to achieving trust and confidence of healthcare professionals and patients across the globe. It has become one of the leading exporters of pharmaceutical finished products of Bangladesh within a couple of years after stepping beyond the native market. At the age of globalization, the world has no boundaries. With the aim to cope with the challenges of globalization, Biopharma Limited began export operations in 2006. Currently, we are exporting a wide range of pharmaceutical products under different therapeutic categories. Biopharam Limited has a portfolio that consists of different types of products such as antiulcerants, antibiotics, NSAIDs, antipyretics, vitamins and minerals, cardiovascular, anti-diabetics, antihistamines, antipsychotics, etc. Biopharma Limited always thrives to introduce hi-tech & innovative dosage forms for the betterment of our patients. Its state of the art facility is planned and designed with fine tuned orientation to meet both local and international demands. Biopahrma continuously sets higher standards and has the passion to achieve it all. WHO approved cGMP guidelines are strictly followed at every step during production. Each and every member of the company is working persistently to uphold quality.
Business association with Biopharma Limited will ensure availability of new products at reasonable price along with generic products and will ensure win-win situation between the companies and countries. Biopharma Limited from the very beginning has objectives to contribute to global health sector by providing Quality health products of international standards. We Offer the best services in regards to manufacturing facilities, product development and quality. Within very short period of time, Biopharma Limited received very positive responses from different countries of the world.
Biopharma Manufactures Bioequivalent Products
To expedite its export mission, Biopharma Limited conducted bioequivalence studies on a variety of its products. These bioequivalence reports have already been accepted by the regulatory bodies of several countries and thus, are helping export. Recently, 6 products have been undergone Bioequivalence (BE) Study in US-FDA approved, renowned Contract Research Organization (CRO) and compared with innovate company's products. These BE studies have shown and proven that Biopharma's Products meet Phaceutical and Pharmacological parameters and Bioequivalent to the Originator Brands.
- Maczith 500 Tablet (Azithromycin) is equivalent to Zithromax 500 (Pfizer)
- Mextil 500 Tablet (Cefuroxime) is equivalent to Zinace 500 (GlaxoSmithKline)
- Mextil Powder for Suspension (Cefuroxime) is equivalent to Zinnat Powder for Suspension (GlaxoSmithKline)
- Bestcef 200 Capsule (Cefixime) is equivalent to Tergecef 200 (Unilab)
- Bestcef Powder for Suspension (Cefixime) is equivalent to Tergecef Powder for Suspension (Unilab)
- Inpro 40 Capsule (Omeprazole) is equivalent to Losec 40 (AstraZeneca)